1. Indonesia Stocks

  2. •

    Healthcare

  3. •

    Medical - Care Facilities
PT Sejahteraraya Anugrahjaya Tbk

PT Sejahteraraya Anugrahjaya Tbk

SRAJ.JK
PT Sejahteraraya Anugrahjaya TbkID flagIndonesia Stock Exchange
11,000.00
IDR
- -
- -
134.63TMarket Cap
PT Sejahteraraya Anugrahjaya Tbk
SRAJ.JK
(Indonesia Stock Exchange)

Recent

price

11,000.00

P/E

ratio

- -

div

yld

- -

ROIC.AI

2010
2011
2012
2013
2014
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
2025
TTM
FRC
21.17
25.53
33.94
33.81
40.96
54.02
52.77
57.86
67.17
83.5
106.98
160.36
161.18
208.6
- -
212.21
213.48
Revenue per Share
0.85
0.71
0.83
-8.42
-12.07
-15.9
-8.9
-9.24
-7.95
-6.31
-1.2
13.77
-3.69
-3.21
- -
-16.31
-8.07
Basic EPS, GAAP
-18.83
-24.64
-52.44
-26.22
-5.16
-5.39
-18.58
-37.35
-34.13
-29.29
-43.54
-38.93
-54.99
-49.05
- -
-49.81
-45.48
Free Cash Flow per Basic Share
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
Dividend per Share
70.21
87.49
100.9
126.54
87.63
71.73
72.16
62.92
58.31
52.01
49.78
63.55
59.45
56.24
- -
39.02
50.05
Book Value per Share
78.91
98.9
113.63
189.31
137.19
121.76
157.82
148.76
133.7
127.75
125.18
139.29
137.04
133.99
- -
87.8
99.8
Tangible Book Value per Share
7,047
6,560
5,730
6,550
8,313
8,313
10,918
10,918
12,001
12,001
12,001
12,001
12,000
12,000
- -
12,202
12,239
Basic Weighted Avg Shares
149,178
167,481
194,502
221,474
340,517
449,071
576,182
631,680
806,031
1,002,002
1,283,799
1,924,453
1,934,164
2,503,174
2,340,431
2,589,440
2,612,750
Sales/Revenue/Turnover
5.57
13.09
10.22
-18.72
-28.54
-21.8
-14.85
-13.97
-9.89
-4.51
1.52
12
1.83
4.36
7.48
3.47
4.11
Operating Margin (%)
- -
24,354
28,369
7,915
16,210
16,015
16,141
15,235
16,240
17,364
30,159
51,760
66,127
76,955
82,535
100,593
87,231
Depreciation Expense
6,005
4,639
4,737
-55,121
-100,333
-132,172
-97,222
-100,850
-95,419
-75,670
-14,381
165,308
-44,315
-38,490
-23,513
-199,000
-98,715
Net Income, GAAP
27.75
21.02
25.09
- -
- -
- -
- -
- -
- -
- -
7,675.12
- -
- -
- -
- -
- -
123.17
Effective Tax Rate (%)
4.03
2.77
2.44
-24.89
-29.46
-29.43
-16.87
-15.97
-11.84
-7.55
-1.12
8.59
-2.29
-1.54
-1
-7.69
-3.78
Profit Margin (%)
-19,129
-11,989
-186,863
37,095
69,859
-139,915
542,233
178,428
-226,133
-669,879
-707,973
-1,637,726
-1,157,152
-1,107,277
-1,764,244
917,887
643,357
Working Capital
116,633
167,069
326,107
371,761
292,777
169,597
75,290
173
60,000
163,421
829,686
203,174
1,164,892
1,542,298
1,125,485
4,522,514
3,974,718
LT Debt
556,738
649,356
654,081
1,245,825
1,144,969
1,015,009
1,724,050
1,624,877
1,842,720
1,776,625
1,754,736
1,927,403
1,895,138
1,857,457
1,833,304
1,335,725
1,471,657
Total Equity
0.91
2.22
1.47
- -
- -
- -
- -
- -
- -
- -
-61.06
- -
- -
- -
- -
- -
1.21
Return on Invested Capital (%)
1.01
2.58
1.55
- -
- -
- -
- -
- -
- -
- -
-420.83
- -
- -
- -
- -
- -
-2.45
Return on Capital (%)
1.3
0.87
0.82
-7.84
-12.89
-19.95
-14.05
-13.68
-13.76
-11.43
-2.35
24.31
-6
-5.55
-3.55
-35.3
-15.22
Return on Common Equity (%)

Capital Structure

FRC

•

in mil. unless spec.
Dec'24
Mar'25
Jun'25
ST Debt
543,657
544,775
556,256
LT Borrowings
1,122,880
3,955,528
3,972,321
LT Finance Leases
2,605
2,605
2,397
Preferred Equity and Hybrid Capital
- -
- -
- -
Shares Outstanding
12,001
12,239
12,239
Market Capitalization
28,321,665
30,107,842
47,854,334

Working Capital

FRC

•

in mil. unless spec.
Dec'24
Mar'25
Jun'25
Total Current Assets
832,802
2,769,165
2,665,210
Cash, Cash Equivalents & STI
277,208
2,172,379
2,050,885
Accounts Receivable, Net
424,298
456,244
498,936
Inventories
61,316
64,691
56,624
Total Current Liabilities
2,597,046
2,053,305
2,021,853
Payables & Accruals
- -
- -
- -
ST Debt
543,657
544,775
556,256
Deferred Revenue
- -
- -
- -

Growth Rates

FRC

•

in mil. unless spec.

(avg. rate of change)

10 years
5 years
1 year
Total Equity
5.04%
-4.45%
-27.14%
Free Cash Flow
51.34%
4.9%
14.12%
Net Income, GAAP
-81.18%
-136.41%
746.34%
Sales/Revenue/Turnover
20.19%
16.79%
10.64%
Total Cash Common Dividend
- -
- -
- -

Quarterly Revenue

FRC

•

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2024
746,135
768,287
817,003
816,920
2,340,431
2025
590,384
388,443
714,372
- -
2,589,440
2026
644,900
- -
- -
- -
- -

Quarterly Earnings Per Share

FRC

•

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2024
0.4
- -
- -
- -
- -
2025
-2.33
- -
- -
- -
-16.31
2026
-7.4
- -
- -
- -
- -

Quarterly Dividends Per Share

FRC

•

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2024
- -
- -
- -
- -
- -
2025
- -
- -
- -
- -
- -
2026
- -
- -
- -
- -
- -
Similar Companies
Revitalist Lifestyle and Wellness Ltd. (RVLWF)
Fresenius SE & Co. KGaA (FSNUY)
U.S. NeuroSurgical Holdings, Inc. (USNU)
Etao International Co., Ltd. (ETAOF)
Master Style Public Company Limited (MASTER.BK)
Ladprao General Hospital Public Company Limited (LPH.BK)
Business
PT Sejahteraraya Anugrahjaya Tbk delivers comprehensive healthcare services across Indonesia. The enterprise focuses on operating a network of modern hospitals, distinguished by the Mayapada Hospital brand, which offer a wide array of specialized medical treatments. These facilities encompass both extensive inpatient and outpatient care, supported by various centers of excellence including neuroscience, cardiovascular, oncology, and orthopedic specialties. Established in 1991 and headquartered in Tangerang, Indonesia, the company has expanded its presence to seven major cities, targeting the middle-to-upper market segment with high-quality medical provisions. Notable developments include a significant investment from Bain Capital in December 2024 to further scale its operations and an ongoing expansion plan to increase its hospital count to nine by 2027, enhancing bed capacity and introducing new facilities in strategic locations. Mayapada Hospital South Jakarta received international accreditation from the Joint Commission International in 2023. PT Sejahteraraya Anugrahjaya Tbk functions as a subsidiary of PT Surya Cipta Inti Cemerlang.